When compared to MTA cells, MTB-01 cells were susceptible to
risedronateinduced apoptosis, had decreased ability to bind to
risedronate-treated bone, and did not produce MMP-2 or MMP-9
proteases. MTA cells were less susceptible to risedronateinduced
apoptosis and produced MMP-2. Additionally, adhesion of MTA cells
to bone matrix was not diminished by risedronate treatment. Our
results suggest that the nonresponsive nature of the MTA cell line
may be due to MMP-2 production (possibly allowing ongoing
destruction of risedronate-treated bone), continued adhesion to
risedronate-treated bone matrix, and decreased susceptibility to
risedronate-induced apoptosis.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!